Contineum Therapeutics, Inc.
CTNM · Pharmaceutical Preparations · 23.1M shares · -99%/yr ↓ buyback · EDGAR filings ↗
Net buyback after stock comp: -$7M (gross $28K, SBC $7M)
Reference price $13.16 · est. market cap ~$304M — last insider sale, 2026-06-01 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D46Clinical/early-stage biotech — neuroscience clinical, extremely cash-rich.
Strengths
- Liquidity — current ratio 27.5 (98th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Exec changeRecent 8-K item 5.02 8-K ↗
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Cash burnNegative free cash flow (-55.5M)
- Buying back stockNet buyback — share count -99%/yr over 1y
- Strong balance sheetStrong balance sheet — $263M cash & investments, ~19 quarters of runway
- New fund positionNotable fund(s) opened this quarter: CITADEL ADVISORS LLC
- AccumulatingInstitutional holders rose 9→10 QoQ (2025-12-31→2026-03-31)
- Insider sellingInsider selling — 19 open-market sale(s) by 3 insider(s) (cluster of 3 insiders, ~$697,704, last 6mo) Form 4 ↗
- Notable holderHeld by 5 notable fund(s): FMR LLC, CITADEL ADVISORS LLC, GOLDMAN SACHS GROUP INC +2 more (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Return on equity
-23.0%
Return on assets
-21.7%
Current ratio
27.5×
Free cash flow
-$56M
EBITDA
-$68M
Tangible book value
$261M
Cash & investments
$263M
Cash runway
19q
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-01 | Lorrain Daniel S. | Sell | 4.2K | $13.16 |
| 2026-05-01 | Lorrain Daniel S. | Sell | 3.9K | $13.06 |
| 2026-05-01 | Lorrain Daniel S. | Sell | 300 | $13.84 |
| 2026-04-06 | Lorrain Daniel S. | Sell | 4.2K | $13.43 |
| 2026-03-02 | Lorrain Daniel S. | Sell | 4.2K | $15.01 |
| 2026-03-02 | Watkins Tim | Option exercise | 3.6K | $4.50 |
| 2026-03-02 | Watkins Tim | Sell | 3.6K | $15.02 |
| 2026-02-25 | Lorrain Daniel S. | Sell | 3.8K | $16.01 |
| 2026-02-25 | Stengone Carmine N. | Option exercise | 2.7K | $1.26 |
| 2026-02-25 | Stengone Carmine N. | Sell | 2.7K | $16.02 |
| 2026-02-25 | Lorrain Daniel S. | Option exercise | 3.8K | $1.01 |
| 2026-02-24 | Lorrain Daniel S. | Option exercise | 4.3K | $1.01 |
| 2026-02-24 | Stengone Carmine N. | Sell | 4.4K | $16.02 |
| 2026-02-24 | Lorrain Daniel S. | Sell | 4.3K | $16.03 |
| 2026-02-24 | Stengone Carmine N. | Option exercise | 4.4K | $1.26 |
| 2026-02-19 | Lorrain Daniel S. | Option exercise | 100 | $1.01 |
| 2026-02-19 | Lorrain Daniel S. | Sell | 100 | $16.00 |
| 2026-02-11 | Stengone Carmine N. | Option exercise | 400 | $1.26 |
| 2026-02-11 | Stengone Carmine N. | Sell | 400 | $16.00 |
| 2026-02-11 | Lorrain Daniel S. | Option exercise | 400 | $1.01 |
| 2026-02-11 | Lorrain Daniel S. | Sell | 400 | $16.00 |
| 2026-02-03 | Lorrain Daniel S. | Sell | 3.0K | $14.82 |
| 2026-02-03 | Lorrain Daniel S. | Sell | 1.2K | $15.25 |
| 2026-01-28 | Watkins Tim | Option exercise | 3.6K | $4.50 |
| 2026-01-28 | Watkins Tim | Sell | 2.8K | $14.09 |
| 2026-01-28 | Watkins Tim | Sell | 811 | $14.48 |
| 2026-01-05 | Lorrain Daniel S. | Sell | 3.7K | $10.35 |
| 2026-01-05 | Lorrain Daniel S. | Sell | 500 | $11.13 |
| 2025-12-29 | Watkins Tim | Option exercise | 3.6K | $4.50 |
| 2025-12-29 | Watkins Tim | Sell | 3.6K | $12.06 |
| 2025-12-23 | Lorrain Daniel S. | Sell | 4.2K | $12.23 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-26 | Shareholder vote | filing ↗ |
| 2026-05-05 | ResultsExhibits | filing ↗ |
| 2026-04-30 | Reg FDOtherExhibits | filing ↗ |
| 2026-03-05 | ResultsOtherExhibits | filing ↗ |
| 2026-01-26 | Exec/director changeExhibits | filing ↗ |
| 2025-12-15 | Material agreementOtherExhibits | filing ↗ |
| 2025-12-11 | OtherExhibits | filing ↗ |
| 2025-11-20 | OtherExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-26 | 2026-06-26 | 0001628280-26-045804 ↗ |
| 8-K | 2026-05-05 | 2026-05-05 | 0001628280-26-030522 ↗ |
| 10-Q | 2026-05-05 | 2026-03-31 | 0001628280-26-030614 ↗ |
| 8-K | 2026-04-30 | 2026-04-30 | 0001628280-26-028876 ↗ |
| 10-K | 2026-03-05 | 2025-12-31 | 0001628280-26-015165 ↗ |
| 8-K | 2026-03-05 | 2026-03-05 | 0001628280-26-015159 ↗ |
| 8-K | 2026-01-26 | 2026-01-23 | 0001437749-26-002072 ↗ |
| 8-K | 2025-12-15 | 2025-12-11 | 0001437749-25-037842 ↗ |
| 8-K | 2025-12-11 | 2025-12-08 | 0001437749-25-037547 ↗ |
| 8-K | 2025-11-20 | 2025-11-20 | 0001437749-25-035860 ↗ |
| 10-Q | 2025-10-30 | 2025-09-30 | 0001437749-25-032427 ↗ |
| 8-K | 2025-10-30 | 2025-10-30 | 0001437749-25-032422 ↗ |